AstraZeneca (NYSE: AZN) announced a global licence agreement with Synairgen Plc, an AIM-listed UK company specialising in respiratory diseases, for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE